SCHOTT Introduces Cartridge Design for High-Speed Filling - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

SCHOTT Introduces Cartridge Design for High-Speed Filling


At INTERPHEX last month, SCHOTT Pharmaceutical Systems introduced glass cartridges that have been developed specifically for the use on high-speed filling lines. The new design enables quicker processing and reduces overfill losses, the company said in a press release.

More companies are using high-speed filling lines to meet the growing demand for insulin products, and the trend is expected to spread to other products, such as dental cartridges. High-speed filling lines, which can fill up to 600 cartridges per minute, have special quality requirements for cartridges. SCHOTT, in partnership with lead customers, translated these process requirements into a new product design that includes defining the neck specification with respect to straightness and cosmetic defects. Manufacturing for the cartridges will be piloted in St. Gallen, Switzerland, where SCHOTT’s competence center for cartridges is based and from where modifications to manufacturing will be managed globally.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
29%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here